WHO ICTRP trial
Effect of Transjugular Intrahepatic Portosystemic Shunt on pharmacokinetics
NL-OMON24097 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON24097 |
|---|---|
| Public title | Effect of Transjugular Intrahepatic Portosystemic Shunt on pharmacokinetics |
| Scientific title | TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS): EFFECT ON PHARMACOKINETICS |
| Primary sponsor | Academic Medical Center (AMC), Amsterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | Cirrhosis, portal hypertension. Levercirrose, portale hypertensie. |
| Interventions | This study consists of three interventions per patient. Patients will receive a single oral administration of a drug cocktail two weeks before TIPS placement, a day after TIPS placement, and twelve weeks after TIPS placement. The oral drug… |
| Registration date | Jan 8, 2019 |
| Target size | 11 |
| Secondary IDs | NL7465;NTR7707;MEC AMC : 2018_089 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: